about
Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with CarboplatinSystematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's diseaseA natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicityLocalized drug application and sub-second voltammetric dopamine release measurements in a brain slice perfusion device.Massively parallel C. elegans tracking provides multi-dimensional fingerprints for phenotypic discovery.Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by TrodusquemineTrodusquemine enhances Aβ aggregation but suppresses its toxicity by displacing oligomers from cell membranesRegional differences in dopamine release in the R6/2 mouse caudate putamen.
P50
Q27300384-DB323C0A-AA04-4BD9-8B7C-CDB8FD0676B1Q28468287-75F5A538-1EE4-462F-95C0-AFE55498E235Q30838501-A91128CB-8FF4-4161-AB7D-9E69944E2FD2Q33598679-B2D7C862-3473-489D-8F0B-25D15A03BC7CQ49923233-A6EB4177-A5E5-4023-BA8D-4F89C6A28C8EQ57986239-FE98A32F-E8DC-4A3B-987E-4D33D7D01A69Q60908258-8D0ADE11-FE68-46B0-82A3-A8C3A3253141Q64898638-D472751A-F678-4ABA-9367-69FEEC38E14C
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-6030-6656
@en
name
Ryan Limbocker
@ast
Ryan Limbocker
@en
Ryan Limbocker
@es
Ryan Limbocker
@nl
type
label
Ryan Limbocker
@ast
Ryan Limbocker
@en
Ryan Limbocker
@es
Ryan Limbocker
@nl
prefLabel
Ryan Limbocker
@ast
Ryan Limbocker
@en
Ryan Limbocker
@es
Ryan Limbocker
@nl
P106
P31
P496
0000-0002-6030-6656